Nuveen Asset Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.06M | Hold |
317,301
| – | – | ﹤0.01% | 2374 |
|
|
2024
Q3 | $1.76M | Hold |
317,301
| – | – | ﹤0.01% | 2482 |
|
|
2024
Q2 | $1.77M | Buy |
317,301
+11,636
| +4% | +$64.9K | ﹤0.01% | 2444 |
|
|
2024
Q1 | $2.05M | Sell |
305,665
-12,081
| -4% | -$81.1K | ﹤0.01% | 2391 |
|
|
2023
Q4 | $2.9M | Buy |
317,746
+8,436
| +3% | +$76.9K | ﹤0.01% | 2236 |
|
|
2023
Q3 | $1.71M | Sell |
309,310
-64
| -0% | -$353 | ﹤0.01% | 2365 |
|
|
2023
Q2 | $2.64M | Sell |
309,374
-625,087
| -67% | -$5.34M | ﹤0.01% | 2218 |
|
|
2023
Q1 | $8.59M | Sell |
934,461
-234,421
| -20% | -$2.15M | ﹤0.01% | 1577 |
|
|
2022
Q4 | $11.9M | Sell |
1,168,882
-171,042
| -13% | -$1.75M | ﹤0.01% | 1376 |
|
|
2022
Q3 | $19.7M | Buy |
1,339,924
+895,330
| +201% | +$13.2M | 0.01% | 1020 |
|
|
2022
Q2 | $4.77M | Buy |
444,594
+94,356
| +27% | +$1.01M | ﹤0.01% | 1975 |
|
|
2022
Q1 | $3.98M | Buy |
350,238
+281,263
| +408% | +$3.2M | ﹤0.01% | 2172 |
|
|
2021
Q4 | $1.23M | Buy |
68,975
+45,889
| +199% | +$821K | ﹤0.01% | 2779 |
|
|
2021
Q3 | $494K | Buy |
+23,086
| New | +$494K | ﹤0.01% | 3169 |
|